{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T02:03:07Z","timestamp":1774922587436,"version":"3.50.1"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,11,22]],"date-time":"2023-11-22T00:00:00Z","timestamp":1700611200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,11,22]],"date-time":"2023-11-22T00:00:00Z","timestamp":1700611200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003243","name":"Ministerstvo Zdravotnictv\u00ed Cesk\u00e9 Republiky","doi-asserted-by":"publisher","award":["00064203"],"award-info":[{"award-number":["00064203"]}],"id":[{"id":"10.13039\/501100003243","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Central retinal artery occlusion (CRAO) is an ophthalmologic emergency that can lead to irreversible loss of vision. Intravenous thrombolysis (IVT) has been used experimentally for its treatment. Our study aimed to evaluate the effect of emergency IVT on CRAO and its impact on visual acuity outcomes. We conducted a retrospective observational study of patients with CRAO. A total of 46 patients with CRAO were analysed; 16 patients received IVT treatment (IVT group) while 30 did not (no-IVT group). Seven patients from the IVT group received IVT early, within 4.5\u00a0hours (h) after the onset of symptoms (early-IVT), and 9 patients received it beyond this timeframe (late-IVT). The median time-to-hospital was 8.5\u00a0h: 3\u00a0h for the IVT group and 24\u00a0h for the no-IVT group. The median time-to-treatment was 5\u00a0h. The median outcome of visual acuity was 0.05 in the early-IVT, 0.025 in the late-IVT, and 0.01 in the no-IVT group. Among patients who received IVT early, 86% exhibited significant visual improvement. This improvement was four-fold greater compared to all other groups (p\u2009=\u20090.040), including the late-IVT (p\u2009=\u20090.011) and no-IVT groups (p\u2009=\u20090.023). No complications of the treatment were reported. Our study confirms that the administration of IVT treatment for CRAO within the 4.5-h time window is both safe and effective.<\/jats:p>","DOI":"10.1038\/s41598-023-47987-9","type":"journal-article","created":{"date-parts":[[2023,11,22]],"date-time":"2023-11-22T16:02:25Z","timestamp":1700668945000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Long-term outcomes of intravenous fibrinolysis in central retinal artery occlusion"],"prefix":"10.1038","volume":"13","author":[{"given":"Pavel","family":"Kozner","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Libor","family":"Eichenmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie","family":"Ceska Burdova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marketa","family":"Pavlikova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Hlozanek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dagmar","family":"Dotrelova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,11,22]]},"reference":[{"key":"47987_CR1","doi-asserted-by":"publisher","first-page":"e282","DOI":"10.1161\/STR.0000000000000366","volume":"52","author":"B Mac Grory","year":"2021","unstructured":"Mac Grory, B. et al. Management of central retinal artery occlusion: A scientific statement from the American heart association. Stroke 52, e282\u2013e294. https:\/\/doi.org\/10.1161\/STR.0000000000000366 (2021).","journal-title":"Stroke"},{"issue":"7","key":"47987_CR2","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1016\/j.ophtha.2010.03.061","volume":"117","author":"M Schumacher","year":"2010","unstructured":"Schumacher, M. et al. Central retinal artery occlusion: Local intra-arterial fibrinolysis versus conservative treatment, a multicenter randomized trial. Ophthalmology 117(7), 1367\u20131375. https:\/\/doi.org\/10.1016\/j.ophtha.2010.03.061 (2010).","journal-title":"Ophthalmology"},{"key":"47987_CR3","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.preteyeres.2015.06.001","volume":"49","author":"D McLeod","year":"2015","unstructured":"McLeod, D. & Beatty, S. Evidence for an enduring ischaemic penumbra following central retinal artery occlusion, with implications for fibrinolytic therapy. Prog. Retin. Eye Res. 49, 82\u2013119. https:\/\/doi.org\/10.1016\/j.preteyeres.2015.06.001 (2015).","journal-title":"Prog. Retin. Eye Res."},{"issue":"4","key":"47987_CR4","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1016\/s0161-6420(01)01011-9","volume":"109","author":"R Foroozan","year":"2002","unstructured":"Foroozan, R., Savino, P. J. & Sergott, R. C. Embolic central retinal artery occlusion detected by orbital color Doppler imaging. Ophthalmology 109(4), 744\u2013747. https:\/\/doi.org\/10.1016\/s0161-6420(01)01011-9 (2002).","journal-title":"Ophthalmology"},{"issue":"3","key":"47987_CR5","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/j.ajo.2005.03.038","volume":"140","author":"SS Hayreh","year":"2005","unstructured":"Hayreh, S. S. & Zimmerman, M. B. Central retinal artery occlusion: visual outcome. Am. J. Ophthalmol. 140(3), 376\u2013391. https:\/\/doi.org\/10.1016\/j.ajo.2005.03.038 (2005).","journal-title":"Am. J. Ophthalmol."},{"issue":"7","key":"47987_CR6","doi-asserted-by":"publisher","first-page":"2018","DOI":"10.1161\/STROKEAHA.119.028743","volume":"51","author":"B Mac Grory","year":"2020","unstructured":"Mac Grory, B. et al. Intravenous fibrinolysis for central retinal artery occlusion: A cohort study and updated patient-level meta-analysis. Stroke 51(7), 2018\u20132025. https:\/\/doi.org\/10.1161\/STROKEAHA.119.028743 (2020).","journal-title":"Stroke"},{"issue":"10","key":"47987_CR7","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1001\/jamaneurol.2015.1578","volume":"72","author":"M Schrag","year":"2015","unstructured":"Schrag, M. et al. Intravenous fibrinolytic therapy in central retinal artery occlusion a patient-level meta-analysis. JAMA Neurol. 72(10), 1148\u20131154. https:\/\/doi.org\/10.1001\/jamaneurol.2015.1578 (2015).","journal-title":"JAMA Neurol."},{"key":"47987_CR8","doi-asserted-by":"publisher","first-page":"e344","DOI":"10.1161\/STR.0000000000000211","volume":"50","author":"WJ Powers","year":"2019","unstructured":"Powers, W. J. et al. Guidelines for the early management of patients with acute ischemic stroke: 2019 Update to the 2018 guidelines for the early management of acute ischemic stroke: A Guideline for healthcare professionals from the American Heart Association\/American Stroke Association. Stroke 50, e344\u2013e418. https:\/\/doi.org\/10.1161\/STR.0000000000000211 (2019).","journal-title":"Stroke"},{"issue":"1","key":"47987_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/2396987321989865","volume":"6","author":"E Berge","year":"2021","unstructured":"Berge, E. et al. European Stroke Organisation (ESO) guidelines on intravenous thrombolysis for acute ischaemic stroke. Eur. Stroke J. 6(1), 1\u201362. https:\/\/doi.org\/10.1177\/2396987321989865 (2021).","journal-title":"Eur. Stroke J."},{"issue":"4","key":"47987_CR10","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1159\/000330462","volume":"32","author":"WD Heiss","year":"2011","unstructured":"Heiss, W. D. The ischemic penumbra: Correlates in imaging and implications for treatment of ischemic stroke. The Johann Jacob Wepfer award 2011. Cerebrovasc. Dis. 32(4), 307\u2013320. https:\/\/doi.org\/10.1159\/000330462 (2011).","journal-title":"Cerebrovasc. Dis."},{"issue":"7","key":"47987_CR11","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1177\/1747493016687578","volume":"12","author":"C Pr\u00e9terre","year":"2017","unstructured":"Pr\u00e9terre, C. et al. Management of acute central retinal artery occlusion: Intravenous thrombolysis is feasible and safe. Int. J. Stroke 12(7), 720\u2013723. https:\/\/doi.org\/10.1177\/1747493016687578 (2017).","journal-title":"Int. J. Stroke"},{"issue":"8","key":"47987_CR12","doi-asserted-by":"publisher","first-page":"2229","DOI":"10.1161\/STROKEAHA.111.613653","volume":"42","author":"CS Chen","year":"2011","unstructured":"Chen, C. S. et al. Efficacy of intravenous tissue-type plasminogen activator in central retinal artery occlusion: Report from a randomized, controlled trial. Stroke 42(8), 2229\u20132234. https:\/\/doi.org\/10.1161\/STROKEAHA.111.613653 (2011).","journal-title":"Stroke"},{"issue":"5","key":"47987_CR13","doi-asserted-by":"publisher","first-page":"e0198114","DOI":"10.1371\/journal.pone.0198114","volume":"13","author":"M Schultheiss","year":"2018","unstructured":"Schultheiss, M. et al. Intravenous thrombolysis in acute central retinal artery occlusion: A prospective interventional case series. PLoS ONE 13(5), e0198114. https:\/\/doi.org\/10.1371\/journal.pone.0198114 (2018).","journal-title":"PLoS ONE"},{"issue":"4","key":"47987_CR14","doi-asserted-by":"publisher","first-page":"388","DOI":"10.3928\/1081-597X-19970701-16","volume":"13","author":"JT Holladay","year":"1997","unstructured":"Holladay, J. T. Proper method for calculating average visual acuity. J. Refract. Surg. 13(4), 388\u2013391. https:\/\/doi.org\/10.3928\/1081-597X-19970701-16 (1997).","journal-title":"J. Refract. Surg."},{"issue":"3","key":"47987_CR15","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1161\/STROKEAHA.119.027034","volume":"51","author":"EM Schorr","year":"2020","unstructured":"Schorr, E. M. et al. Characteristics and outcomes of retinal artery occlusion: Nationally representative data. Stroke 51(3), 800\u2013807. https:\/\/doi.org\/10.1161\/STROKEAHA.119.027034 (2020).","journal-title":"Stroke"},{"issue":"2","key":"47987_CR16","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1161\/STROKEAHA.119.027478","volume":"51","author":"B Mac Grory","year":"2020","unstructured":"Mac Grory, B., Lavin, P., Kirshner, H. & Schrag, M. Thrombolytic therapy for acute central retinal artery occlusion. Stroke 51(2), 687\u2013695. https:\/\/doi.org\/10.1161\/STROKEAHA.119.027478 (2020).","journal-title":"Stroke"},{"key":"47987_CR17","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.ajo.2018.08.027","volume":"196","author":"P Lavin","year":"2018","unstructured":"Lavin, P. et al. Stroke risk and risk factors in patients with central retinal artery occlusion. Am. J. Ophthalmol. 196, 96\u2013100. https:\/\/doi.org\/10.1016\/j.ajo.2018.08.027 (2018).","journal-title":"Am. J. Ophthalmol."},{"issue":"4","key":"47987_CR18","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1007\/s40123-021-00360-3","volume":"10","author":"JLJ Claessens","year":"2021","unstructured":"Claessens, J. L. J. et al. Digital tools for the self-assessment of visual acuity: A systematic review. Ophthalmol. Ther. 10(4), 715\u2013730. https:\/\/doi.org\/10.1007\/s40123-021-00360-3 (2021).","journal-title":"Ophthalmol. Ther."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-47987-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-47987-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-47987-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,22]],"date-time":"2023-11-22T16:14:36Z","timestamp":1700669676000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-47987-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,22]]},"references-count":18,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["47987"],"URL":"https:\/\/doi.org\/10.1038\/s41598-023-47987-9","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,22]]},"assertion":[{"value":"3 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 November 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 November 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"20505"}}